Mood and anxiety disorders in women with treated hyperthyroidism and ophthalmopathy caused by Graves' disease

被引:63
作者
Bunevicius, R [1 ]
Velickiene, D
Prange, AJ
机构
[1] Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27599 USA
[2] Kaunas Univ Med, Inst Endocrinol, LT-50009 Kaunas, Lithuania
关键词
Graves' disease; mood; anxiety; ophthalmopathy;
D O I
10.1016/j.genhosppsych.2004.10.002
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: To evaluate the prevalence of mood and anxiety disorders in women with treated hyperthyroidism caused by Graves' disease and to compare them with the prevalence of such findings in women without past or present thyroid disease. Methods: Thirty inpatient women with treated hyperthyroidism and ophthalmopathy caused by Graves' disease and 45 women hospitalized for treatment of gynecologic disorders such as abnormal vaginal bleeding, benign tumors or infertility were evaluated for the prevalence of mood and anxiety diagnoses using a standard Mini-International Neuropsychiatric Interview and for mood and anxiety ratings using the Profile of Mood States (POMS). At the time of assessment, it was discovered that 14 of 30 women with treated hyperthyroidism caused by Graves' disease were still hyperthyroid, while 16 women were euthyroid. Results: Significantly greater prevalence of social anxiety disorder, generalized anxiety disorder, major depression and total mood and anxiety disorders, as well as higher symptom scores on the POMS, was found in hyperthyroid women with Graves' disease in comparison with the control group. A prevalence of total anxiety disorder, as well as history of mania or hypomania and lifetime bipolar disorder, but not lifetime unipolar depression, was more frequent in both the euthyroid and the hyperthyroid subgroups of study women in comparison with the control group. Conclusions: These results confirm a high prevalence of mood and anxiety disorders in women with treated hyperthyroidism and ophthalmopathy caused by Graves' disease. Hyperthyroidism plays a major role in psychiatric morbidity in Graves' disease. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:133 / 139
页数:7
相关论文
共 45 条
[11]   Depression and anxiety in hyperthyroidism [J].
Demet, MM ;
Özmen, B ;
Deveci, A ;
Boyvada, S ;
Adigüzel, H ;
Aydemir, Ö .
ARCHIVES OF MEDICAL RESEARCH, 2002, 33 (06) :552-556
[12]   Long-term residual complaints and psychosocial sequelae after remission of hyperthyroidism [J].
Fahrenfort, JJ ;
Wilterdink, AML ;
van der Veen, EA .
PSYCHONEUROENDOCRINOLOGY, 2000, 25 (02) :201-211
[13]   The relationship of psychological factors to the prognosis of hyperthyroidism in antithyroid drug-treated patients with Graves' disease [J].
Fukao, A ;
Takamatsu, J ;
Murakami, Y ;
Sakane, S ;
Miyauchi, A ;
Kuma, K ;
Hayashi, S ;
Hanafusa, T .
CLINICAL ENDOCRINOLOGY, 2003, 58 (05) :550-555
[14]   Adverse CNS-effects of beta-adrenoceptor blockers [J].
Gleiter, CH ;
Deckert, J .
PHARMACOPSYCHIATRY, 1996, 29 (06) :201-211
[15]   BORDERLINE HYPOTHYROIDISM AND DEPRESSION [J].
HAGGERTY, JJ ;
PRANGE, AJ .
ANNUAL REVIEW OF MEDICINE, 1995, 46 :37-46
[16]   Psychosocial factors in subjects with thyroid-associated ophthalmopathy [J].
Kahaly, GJ ;
Hardt, J ;
Petrak, F ;
Egle, UT .
THYROID, 2002, 12 (03) :237-239
[17]   THE RELATIONSHIP OF ANXIETY AND DEPRESSION TO SYMPTOMS OF HYPERTHYROIDISM USING OPERATIONAL CRITERIA [J].
KATHOL, RG ;
DELAHUNT, JW .
GENERAL HOSPITAL PSYCHIATRY, 1986, 8 (01) :23-28
[18]   Local activation and inactivation of thyroid hormones:: the deiodinase family [J].
Köhrle, J .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1999, 151 (1-2) :103-119
[19]  
LARSEN PR, 1982, NEW ENGL J MED, V306, P23
[20]   EMOTIONAL DISTURBANCE AND COGNITIVE DEFICITS IN HYPER-THYROIDISM [J].
MACCRIMMON, DJ ;
WALLACE, JE ;
GOLDBERG, WM ;
STREINER, DL .
PSYCHOSOMATIC MEDICINE, 1979, 41 (04) :331-340